Study blood and tissue markers in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have pancreatic cancer that has been confirmed by pathology (microscope test)
- Your diagnosis is either pancreatic duct cancer or ampullary cancer, if it was resected (removed) or otherwise confirmed based on clinical and scan findings
- Be able to provide the resected tissue specimen if you had surgery, or the appropriate pathology confirmation if you did not
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study collects samples of substances in your blood to learn more about pancreatic cancer. It may help researchers find better ways to track the disease or understand which patients may benefit from future treatments.
This study looks for new markers in the blood or tissue of people with a pancreatic mass that might be cancer. It uses samples from a routine biopsy or surgery to help doctors learn more about the disease.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.